This section provides a non-exhaustive list of the non-approval decisions that are applicable to all European countries. They are specific to an active substance/ product type combination.

Commission implementing Decision (EU) 2023/1424 of 5 July 2023 not renewing the approval of acrolein for use in biocidal products of product-type 12 in accordance with Regulation ( EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2023/1097 of 5 June 2023 not approving cyanamide as an existing active substance for use in biocidal products of product-types 3 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/4470 of 2 March 2023 not approving d-Allethrin as an existing active substance for use in biocidal products of product-types 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-types 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2023/458 of 1 March 2023 of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2570 of 24 November 2022 not approving silver nitrate as an active substance for use in biocidal products of product-types 7 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2327 of 24 November 2022 not approving chloramin B as an active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2326 of 24 November 2022 not approving epsilon-metofluthrin as an active substance for use in biocidal products of producttype 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2325 of 24 November 2022 not approving 1,2-benzisothiazol-3(2H)-one (BIT) as an active substance for use in biocidal products of product-type 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2005 of 21 October 2022 not approving methylene dithiocyanate as an existing active substance for use in biocidal products of product-type 12 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/1990 of 20 October 2022 cancelling the approval of tolylfluanid as an active substance for use in biocidal products of producttype 7 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/986 of 23 June 2022 not approving N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine as an existing active substance for use in biocidal products of product-type 8

Commission implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2021/103 of 29 January 2021 not approving carbon dioxide as an existing active substance for use in biocidal products for product-type 19

Commission implementing Decision (EU) 2021/98 of 28 January 2021 not approving esbiothrin as an existing active substance for use in biocidal products for product-type 18

Commission implementing Decision (EU) 2020/1765 of 25 November 2020 not approving chlorophene as an existing active substance for use in biocidal products for product-type 2

Commission implementing Decision (EU) 2020/1036 of 15 July 2020 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2019/1973 of 27 november 2019 not approving silver copper zeolite as an existing active substance for use in biocidal products for product-type 2 and 7

Commission implementing Decision (EU) 2019/1960 of 26 november 2019 not approving silver zeolite as an existing active substance for use in biocidal products for product-type 2 and 7

Commission implementing Decision (EU) 2019/1959 of 26 november 2019 not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products for product-type 2 and 7

Commission implementing Decision (EU) 2019/1942 of 22 november 2019 not approving carbendazim as an existing active substance for use in biocidal products for product-type 9

Corrigendum to commission implementing Decision (EU) 2018/1622 of 29 October 2018 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2018/1985 of 13 december 2018 not approving "Willaertia magma C2c Maky" as an active substance for use in biocidal products for product-type 11

Commission implementing Decision (EU) 2018/1622 of 29 October 2018 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2018/1251 of 18 September 2018 not approving empenthrin as an existing active substance for use in biocidal products for product-type 18

Commission implementing Decision (EU) 2018/622 of 20 April 2018 not approving chlorophene as an existing active substance for use in biocidal products for product-type 3

Commission implementing Decision (EU) 2018/619 of 20 April 2018 not approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products for product-type 1,  5 and 6

Commission implementing Decision (EU) 2017/1282 of 14 July 2017 not approving 2-méthyl-1,2-benzisothiazol-3(2H)-one as an existing active substance for use in biocidal products for product-type 13

Commission implementing Decision (EU) 2017/802 of 10 May 2017 not approving PHMB (1600; 1.8) as an existing active substance for use in biocidal products for product-type 5

Commission implementing Decision (EU) 2016/1950 of 4 November 2016 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2016/110 of 27 January 2016 not approving triclosan as an active substance for use in biocidal products for product-type 1

Commission implementing Decision (EU) 2016/109 of 27 January 2016 not to approve PHMB (1600; 1.8) as an active substance for use in biocidal products for product-types 1, 6 and 9

Commission implementing Decision (EU) 2016/108 of 27 January 2016 not approving 2-Butanone, peroxide as an active substance for use in biocidal products for product-types 1 and 2

Commission implementing Decision (EU) 2016/107 of 27 January 2016 not approving cybutryne as an active substance for use in biocidal products for product-type 21

Commission implementing Decision (EU) 2015/1736 of 28 September 2015 not approving triflumuron as an active substance for use in biocidal products for product-type 18

Commission implementing Decision 2014/227/EU of 24 April 2014 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Decision 2013/204/EU of 27 April 2013 concerning the non-inclusion of formaldehyde for product-type 20 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2013/85/EU of 14 February 2013 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/728/EU of 23 November 2012 concerning the non-inclusion of bifenthrin for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/257/EU of 11 May 2012 concerning the non-inclusion of naled for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/254/EU of 10 May 2012 concerning the non-inclusion of dichlorvos for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/78/EU of 1 February 2012 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/77/EU of 1 February 2012 concerning the non-inclusion of flufenoxuron for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2011/391/EU of 1 July 2011 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2010/675/EU of 8 November 2010 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2010/72/EU of 8 February 2010 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2010/71/EU of 8 February 2010 concerning the non-inclusion of diazinon in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2009/324/EC of 14 April 2009 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2009/322/EC of 8 April 2009 concerning the non-inclusion of certain substances in Annexes I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2008/809/EC of 14 October 2008 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2008/681/EC of 28 July 2008 concerning the non-inclusion of certain substances in Annexes I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2007/597/EC of 27 August 2007 concerning the non-inclusion of guazatine triacetate in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2007/565/EC of 14 August 2007 concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof